Render Target: STATIC
Render Timestamp: 2024-12-23T11:01:03.397Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-11-13 18:56:06.737
Product last modified at: 2024-12-17T18:50:29.368Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Anisomycin #2222

    Product Information

    Product Usage Information

    Anisomycin is supplied as a lyophilized powder. For a 25 mg/ml stock, reconstitute the 10 mg in 400 µl DMSO. Working concentrations and length of treatments vary depending on the desired effect, but it is typically used at 5-50 µg/ml for 5-60 minutes. Soluble in DMSO or MeOH.

    Storage

    Store lyophilized at -20C. Protect from light. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 1 month and store at -20C. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 265.3 g/mol
    Purity >98%
    Molecular Formula C14H19NO4
    CAS 22862-76-6
    Solubility Soluble in DMSO at 100mg/ml and MeOH at 50mg/ml.

    Background

    Anisomycin, an antibiotic produced by Streptomyces griseolus and S. roseochromogenes, was originally described to inhibit protein-protein synthesis at the translational level (1). More recently, it is has been well characterized to strongly activate the stress kinases SAPK/JNK and p38 MAPK, as well as p70/85 S6 kinase in mammalian cells, which results in the rapid induction of immediate-early (IE) genes, such as c-fos, fosB, c-jun, JunB, and JunD (1). Investigators have demonstrated that anisomycin acts as a potent signaling agonist, synergizing with growth factors and phorbol esters to superinduce these IE genes (1,2). Research studies have demonstrated that anisomycin induces apoptosis in many cancer cell lines (3-5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.